Nucleus funded a study on gene editing efficiency
The study led by Dr. Dieter Egli's lab showed near-100% efficiency in human embryo gene editing.
See the latest news and media coverage for Nucleus. We track all announcements, press releases, and industry mentions in real time, all in one place.
Reproductive genomics and personalized health insights company
mynucleus.comLast updated
In short: Nucleus launched genetic optimization services and expanded its global IVF network while facing ethical scrutiny over embryo selection.
The study led by Dr. Dieter Egli's lab showed near-100% efficiency in human embryo gene editing.
Through joint ventures with Indira IVF and Abu Ghosh Fertility Group, Nucleus will integrate embryo screening for health risks beyond rare conditions.
They provide advanced IVF and genetic screening to prevent Huntington's inheritance in children. This ends the disease in affected families.
It screens for rare and common diseases and models traits like eye color and IQ from a cheek swab.
Nucleus Genomics is promising “genetic optimization” for future babies, sparking ethical concerns and doubts over whether the hype is a market lure. But others are...
The Canadian entrepreneur has always pushed the boundaries of gene editing, once attempting to turn horses into unicorns. Now she is set on modifying human...
Biotech startups are screening embryos for various desirable and undesirable traits before choosing what to implant.
Recognition highlights Teradata's enterprise AI capabilities, including Enterprise AgentStack, open-source MCP Server, and in-database vector and analytics infrastructureSAN DIEGO, April 23, ...
Track Nucleus and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Nucleus and other trending companies.